Animal models of hypertension: a scientific statement from the American Heart Association

LO Lerman, TW Kurtz, RM Touyz, DH Ellison… - …, 2019 - Am Heart Assoc
Hypertension is the most common chronic disease in the world, yet the precise cause of
elevated blood pressure often cannot be determined. Animal models have been useful for …

Hypertensive emergencies

CJ Vaughan, N Delanty - The Lancet, 2000 - thelancet.com
A hypertensive emergency is a situation in which uncontrolled hypertension is associated
with acute end-organ damage. Most patients presenting with hypertensive emergency have …

Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy

M Bader - Annual review of pharmacology and toxicology, 2010 - annualreviews.org
The renin-angiotensin-aldosterone system is one of the most important systems in
cardiovascular control and in the pathogenesis of cardiovascular diseases. Therefore, it is …

[HTML][HTML] Renin increases mesangial cell transforming growth factor-β1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms

Y Huang, S Wongamorntham, J Kasting, D McQuillan… - Kidney international, 2006 - Elsevier
Recent evidence suggesting a strong interplay between components of the renin–
angiotensin system and key mediators of fibrosis led us to hypothesize that renin …

Update on tissue renin–angiotensin systems

M Bader, D Ganten - Journal of Molecular Medicine, 2008 - Springer
Angiotensin (Ang) II is not only generated in the circulation by renin and angiotensin-
converting enzyme (ACE) but also is produced locally in numerous organs including kidney …

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research

M Bader, J Peters, O Baltatu, DN Müller, FC Luft… - Journal of molecular …, 2001 - Springer
Renin was first isolated in the kidney by Tigerstedt and Bergman over 100 years ago. Almost
50 additional years were necessary to isolate the renin substrate angiotensinogen and to …

Renin inhibition with aliskiren: where are we now, and where are we going?

M Azizi, R Webb, J Nussberger… - Journal of …, 2006 - journals.lww.com
With the development of aliskiren, blockade of the renin–angiotensin–aldosterone system
(RAAS) at the level of the interaction of renin with a substrate has become a clinical reality …

Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension

R Fischer, R Dechend, F Qadri, M Markovic, S Feldt… - …, 2008 - Am Heart Assoc
We compared the effect n-3 polyunsaturated fatty acids (PUFAs) with direct renin inhibition
on electrophysiological remodeling in angiotensin II–induced cardiac injury. We treated …

Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen …

A Fukamizu, K Sugimura, E Takimoto… - Journal of Biological …, 1993 - Elsevier
A reaction between enzyme renin and its only natural substrate angiotensinogen is the initial
and rate-limiting step for producing a potent vasoconstrictor angiotensin II as the final …

Aliskiren: the first renin inhibitor for clinical treatment

C Jensen, P Herold, HR Brunner - Nature reviews Drug discovery, 2008 - nature.com
The first evidence of the existence of renin was presented over 100 years ago. However, the
importance of renin and the renin–angiotensin system in the pathogenesis of cardiovascular …